Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

Media perspectives: William Looney

In our latest Media Perspectives interview, we speak to William Looney from Pharmaceutical Executive about his highlights as Editor-In-Chief and his thoughts on some of this year’s top pharma news stories. Our Media Perspectives series gives us an insight into the lives of those working within both the media and pharma industries...

Articles

Why training in pharma needs to change behaviours to impact ...

Ashish Rishi provides his thoughts on how behaviours need to be changed within pharma training in order to impact and improve performance. When you meet someone at?a party, what’s one of the first questions that you are typically asked? “So, what do you do then?” Work is fast becoming...

Articles

Pharma gets social: Lilly Oncology on Canvas, a social initi...

In our latest Pharma gets social article, Daniel Ghinn explores the social media strategies of Lilly Oncology on Canvas and provides his thoughts on how the initiative could progress in the future. Two years before Twitter ever existed, Lilly launched a social initiative that encouraged people affected by cancer to share...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.